## Materia licences metathesis catalyst platform to Aileron Therapeutics Materia Inc announced the licensing of its metathesis platform to Aileron Therapeutics, an emerging biopharmaceutical company, for use in the discovery and development of peptide therapeutics directed at intracellular protein-
DONG, Novozymes, and Statoil invest in bioethanol production
- Publisher
- Elsevier Science
- Year
- 2007
- Weight
- 50 KB
- Volume
- 2007
- Category
- Article
- ISSN
- 1351-4180
No coin nor oath required. For personal study only.
โฆ Synopsis
BASF collaborates with Tekion
BASF and Tekion will establish an alliance to develop formic acid for use as fuel for the latter's fuel cell technology. The alliance will set codes and standards, develop and test a custom-made formic acid formulation, and handle materials compatibility for fuel cells. BASF is a worldwide supplier of formic acid while Tekion is a manufacturer of micro-fuel cells for portable electronics.
๐ SIMILAR VOLUMES
nanotechnology sector and EU member states to bring a better understanding of nanomaterials and to provide adequate ways of protecting humans and the environment. The nanotechnology sector is covered by existing legislation such as Reach and specific sector regulations for food, cosmetic and drug se
Engelhard De Meern BV will operate as the Catalysts Division of BASF Nederland BV, reflecting a strong growth by the latter, which has it headquarters in Arnhem. Engelhard de Meern, which had been a subsidiary of the former Engelhard Corp, develops, produces, and sells high-value catalysts and has a
## Cosmo considers widening use of enhanced FCC process Cosmo Oil is considering rolling out its improved fluid-catalytic-cracking (FCC) technology at all its refineries in Japan. The process uses a proprietary catalyst to remove sulfur from gasoline without lowering the gasoline's octane rating. T